VAAS 2025 has officially concluded, marking a meaningful event that brought together leading doctors and experts in the fields of endoscopic surgery, orthopedics, and joint treatment.
Regenogel was honored to accompany VAAS 2025, presenting a joint injection product that combines Hyaluronic Acid (HA) and Fibrinogen – helping to lubricate joints, reduce pain, combat inflammation, and support cartilage regeneration.
The product originates from ProCore – Israel and is now distributed in Vietnam by Regenmed Joint Stock Company for Regenerative Medicine.
We sincerely thank all Doctors and Partners who visited the Regenogel booth at VAAS 2025!
